At a Glance
11.2 Capital is a venture capital firm. The firm focuses on Pre-Seed, Series B+ investments across sectors including AI, Digital Health, Cybersecurity. Early-stage deep-tech investor with rare bioengineering focus, investing in AI, digital health, and cybersecurity.
“Early-stage deep-tech investor with rare bioengineering focus, investing in AI, digital health, and cybersecurity.”
David Dorsey
Partner, 11.2 Capital
Pramod Gosavi
Principal, 11.2 Capital
Shelley Zhuang
Founder and Managing Partner, 11.2 Capital
11.2 Capital primarily invests at the Pre-Seed, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
11.2 Capital is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
11.2 Capital focuses on investments in AI, Digital Health, Cybersecurity. Their portfolio reflects deep expertise and networks within these sectors.
11.2 Capital's typical investment check size ranges from $500K to $3M. Actual amounts may vary based on the stage, sector, and specific opportunity.